Related Experiment Videos

Fusion of Mycoplasma fermentans strain incognitus with T-lymphocytes

G Franzoso1, D S Dimitrov, R Blumenthal

  • 1Laboratory of Mycoplasma, FDA, Bethesda, MD 20892.

FEBS Letters
|June 1, 1992
PubMed

Insights

Mycoplasma fermentans can fuse with lymphocytes, a process dependent on temperature and involving a protein component. This fusion, though limited, was observed in both cultured and primary cells.

Area of Science:

  • Microbiology
  • Cell Biology
  • Immunology

Background:

  • Mycoplasma fermentans is a bacterium known for its ability to interact with host cells.
  • Understanding the mechanisms of microbial-host cell interaction is crucial in infectious disease research.

Purpose of the Study:

  • To investigate and characterize the fusion process between Mycoplasma fermentans (strain incognitus) and cultured lymphocytes.
  • To identify factors influencing the fusion efficiency and mechanism.

Main Methods:

  • Lipid mixing assay using octadecylrhodamine (R18) fluorescent probe to quantify fusion.
  • Fluorescent microscopy for visual confirmation of fusion.
  • Trypan blue staining to assess lymphocyte integrity.
  • Inhibition assays using anti-M. fermentans antisera and proteolytic enzymes.

Main Results:

  • Mycoplasma fermentans fused with both CD4+ and CD4- cultured lymphocytes, as well as primary peripheral blood lymphocytes.
  • Fusion efficiency ranged from 5-10% with cultured cells and reached 12% with primary lymphocytes.
  • Fusion rate was temperature-dependent, completing within 60 minutes at 37°C.
  • Fusion was significantly inhibited by anti-M. fermentans antisera and enzymatic treatment, indicating a protein-mediated process.

Conclusions:

  • Mycoplasma fermentans can fuse with lymphocytes through a temperature-dependent mechanism.
  • A surface-exposed protein on M. fermentans appears to mediate the fusion process.
  • The fusion involves a specific subpopulation of lymphocytes and does not compromise lymphocyte integrity.

Related Concept Videos